Samus Therapeutics Receives IND Clearance from FDA for PU-AD for the Treatment
11 May 2021 //
PRNEWSWIRE
Samus Therapeutics Receives IND Clearance from FDA for PU-AD
11 May 2021 //
BIOSPACE
Samus Therapeutics Presents Phase 1 PU-AD Study Results at AAIC 2020 Advancing
29 Jul 2020 //
PRNEWSWIRE